Provided by Tiger Fintech (Singapore) Pte. Ltd.

ClearPoint Neuro, Inc.

11.85
+0.04000.34%
Volume:41.88K
Turnover:492.17K
Market Cap:334.94M
PE:-15.73
High:11.93
Open:11.83
Low:11.61
Close:11.81
Loading ...

ClearPoint Neuro (CLPT) Gets a Buy from Lake Street

TIPRANKS
·
1 hour ago

ClearPoint Neuro Inc. Conducted Annual Stockholders Meeting

Reuters
·
24 May

ClearPoint Neuro Inc. Announces Revised Compensation Plan for Non-Employee Directors

Reuters
·
20 May

Clearpoint Neuro Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance

Benzinga
·
14 May

ClearPoint Neuro reaffirms FY25 revenue view $36.0M-$41M, consensus $38.23M

TIPRANKS
·
14 May

Clearpoint Neuro Q1 Revenue USD 8.5 Million

THOMSON REUTERS
·
14 May

Clearpoint Neuro Outlook FY Revenue USD 36-41 Million

THOMSON REUTERS
·
14 May

Clearpoint Neuro Q1 Gross Margin 60%

THOMSON REUTERS
·
14 May

ClearPoint Neuro Q1 EPS $(0.22) Misses $(0.16) Estimate, Sales $8.48M Beat $8.20M Estimate

Benzinga
·
14 May

BRIEF-Clearpoint Neuro Inc QTRLY Loss Per Share $0.22

Reuters
·
14 May

Clearpoint Neuro Inc: Reaffirms Its Full Year 2025 Revenue Outlook

THOMSON REUTERS
·
14 May

Clearpoint Neuro Inc Qtrly Shr Loss $0.22

THOMSON REUTERS
·
14 May

ClearPoint Neuro Inc. Secures Additional Note Financing of Up to $105 Million from Oberland Capital

Reuters
·
13 May

Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)

TIPRANKS
·
12 May

Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
10 May

ClearPoint Neuro announces FDA submission to expand ClearPoint Prism labeling

TIPRANKS
·
28 Apr

The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing

Simply Wall St.
·
27 Apr

B. Riley Adjusts Price Target on ClearPoint Neuro to $28 From $20, Maintains Buy Rating

MT Newswires Live
·
25 Apr

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

ACCESS Newswire
·
25 Apr